Auto-focusing spectacles

Article

A trial of electronic spectacles with dynamic focusing lenses has begun enrolling its first wearers, according to an announcement from the spectacles' manufacturer, PixelOptics Inc.

A trial of electronic spectacles with dynamic focusing lenses has begun enrolling its first wearers, according to an announcement from the spectacles' manufacturer, PixelOptics Inc.

The spectacles use a composite of electricity, chemistry and optic technology to focus faster than a blinking eye, providing clear near, intermediate and distance vision. As such, these "electro-active" spectacles would be suitable non-surgical correction for presbyopia. The limited and controlled trials will run throughout the year, ahead of the lenses" anticipated market launch in 2010. PixelOptics claims that the lenses will not differ significantly from traditional lenses in terms of cosmetic factors (such as style, thickness and transparency) and weight. The lenses are lineless and provide a wider and less compromised field of vision than is available with current lenses.

PixelOptics, which concentrates on developing these "composite" lenses, is also developing static focus lenses. It launched its first static composite lens, the atLast! Enhanced Multifocal, which provides enhanced intermediate vision to bifocal and trifocal spectacle wearers, in October 2008. The dynamic electronic lenses will be showcased for the first time at the International Vision Expo East in New York, March 27–29, 2009.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.